Cyteir Therapeutics Presents Preclinical Data Validating RAD51-AID as a Novel Target for Cancer Treatment at American Association of Cancer Research Annual Meeting
FierceBiotech names Fulcrum Therapeutics as one of its “Fierce 15” Biotech Companies of 2016
Harvard University to Open Life Sciences Lab in Allston in November
Announcing the 17 ventures joining the Pagliuca Harvard Life Lab this fall
LabCentral to Host Special Virtual Panel on Biotech Innovation in Space
Eagle Pharmaceuticals Signs Definitive Agreement to Acquire Arsia Therapeutics Marking Entry into Biosimilar Market
Slone Partners Supports the Next Generation of Biotech Leaders Through Sponsorship of LabCentral
